Drug Profile
Hib-DTaP-poliovirus-vaccine - Serum Institute of India
Alternative Names: Diptheria, Tetanus, acellular Pertussis, Poliomyelitis and Haemophilus influenzae type b vaccine; DTaP-IPV+Hib vaccine - Serum; Hib-DTP-acellular-poliovirus vaccine - SerumLatest Information Update: 28 Aug 2021
Price :
$50
*
At a glance
- Originator Serum Institute of India
- Class Bacterial vaccines; Haemophilus vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for phase-I development in Diphtheria(Prevention) in India (Parenteral)
- 28 Aug 2021 No recent reports of development identified for phase-I development in Haemophilus-infections(Prevention) in India (Parenteral)
- 28 Aug 2021 No recent reports of development identified for phase-I development in Pertussis(Prevention) in India (Parenteral)